Form D · Pharmaceuticals
AMARIN CORP PLC\UK
Dublin, L2 · CIK 0000897448
Offering snapshot reported Oct 30, 2009 · SEC filing
- Reported sold
- $70M Offering amount: $70M
- Investors reported
- 36 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Oct 16, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 30, 2009 | Initial | $70,000,000 | No comparison | 36 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.3M
- Finders' fees
- $510K
- Form D file number
- 021-135720
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Cowen and Company LLC | 1716 |
Source: Form D, filed Oct 30, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Anderson | Director |
| Alan Cooke | Executive |
| Lars Ekman | Director |
| Carl L. Gordon | Director |
| James I. Healy | Director |
| Thomas G. Lynch | Director, Executive |
| Manus Rogan | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
First Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge
Dublin, L2, Dublin 4
Dublin, L2, Dublin 4